Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4245488
Max Phase: Preclinical
Molecular Formula: C55H101N19O10
Molecular Weight: 1188.54
Molecule Type: Small molecule
Associated Items:
ID: ALA4245488
Max Phase: Preclinical
Molecular Formula: C55H101N19O10
Molecular Weight: 1188.54
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(N)=O)C(C)C
Standard InChI: InChI=1S/C55H101N19O10/c1-29(2)22-40(66-34(11)75)49(80)71-42(24-31(5)6)51(82)73-43(25-32(7)8)52(83)72-41(23-30(3)4)50(81)68-38(18-15-21-64-55(60)61)48(79)74-44(33(9)10)53(84)69-36(16-12-13-19-56)46(77)67-37(17-14-20-63-54(58)59)47(78)70-39(45(57)76)26-35-27-62-28-65-35/h27-33,36-44H,12-26,56H2,1-11H3,(H2,57,76)(H,62,65)(H,66,75)(H,67,77)(H,68,81)(H,69,84)(H,70,78)(H,71,80)(H,72,83)(H,73,82)(H,74,79)(H4,58,59,63)(H4,60,61,64)/t36-,37-,38-,39-,40-,41-,42-,43-,44-/m0/s1
Standard InChI Key: PAQAQOCZNBOJSG-FSLKYBNLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1188.54 | Molecular Weight (Monoisotopic): 1187.7979 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Dianati V, Kwiatkowska A, Couture F, Desjardins R, Dory YL, Day R.. (2018) Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines., 61 (18): [PMID:30180568] [10.1021/acs.jmedchem.8b01144] |
Source(1):